One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug.
Objectives Educational initiatives in residency may lack alignment with residents’ learning objectives. Furthermore, they may overlook residents’ struggle to find fulfilment in their work. Professional…
A timeline of how Elon Musk has turned X into a misinformation weapon that spews falsehoods about migrants, gender, health and elections.
The Medical College of Wisconsin bestowed its 2024 Alumna of the Year Award to Anne Hanneken, MD, an associate professor in the Department of Molecular…
This study compares knowledge of diagnosis and worry among adults presented with prostate biopsy reports in a patient-centered format, which present important clinical data in…
Dr. Kahn is a summa cum laude graduate of the University of Michigan School of Medicine. He practices cardiology in Detroit, is a clinical professor…
Many healthcare AI developers lack access to real-world data. To address this, Atropos Health is allowing AI developers to train and deploy their models using…
Here are some observations from a recent trip to China, a country I’d never visited before. It was an 8-day trip related to my editor…
Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent appearances on podcasts Fishbowl with Jules Terpak…
Spasticity is a common side effect of certain neurological conditions. Here’s what exercises and stretching approaches experts recommend for spasticity management.
The ARISE II trial could be a game-changer for patients with type A aortic dissection and other ascending aortic pathologies who are at high surgical…
